Clinical Trial Update: Ketamine for Sedation in Severe Traumatic Brain Injury [Phase 4]

View source ↗

Summary

Phase 4 trial studying ketamine for sedation in severe traumatic brain injury has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Intracerebral Hemorrhage
• Intracranial Hemorrhage
• Intracranial Hypertension
• Traumatic Brain Injury

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Severe Traumatic Brain Injury, Intracranial Hypertension | Phase 4 | Status: SUSPENDED